ES2357366T3
(es)
*
|
2002-05-14 |
2011-04-25 |
MERCK SHARP & DOHME CORP. |
Procedimientos de purificación de adenovirus.
|
NZ548495A
(en)
*
|
2004-02-23 |
2009-05-31 |
Crucell Holland Bv |
Virus purification methods
|
ES2647477T3
(es)
*
|
2004-06-01 |
2017-12-21 |
Genzyme Corporation |
Composiciones y métodos para prevenir la agregación del vector AAV
|
KR20070104339A
(ko)
*
|
2004-11-03 |
2007-10-25 |
인트로겐 테라페티스, 인코퍼레이티드 |
아데노바이러스 벡터의 생산과 정제를 위한 신규한 방법
|
JP2008538894A
(ja)
*
|
2005-02-11 |
2008-11-13 |
メルク エンド カムパニー インコーポレーテッド |
アデノウイルス血清型26ベクター、核酸およびそれにより製造されたウイルス
|
DK1869171T4
(da)
|
2005-04-11 |
2016-01-18 |
Crucell Holland Bv |
Virusrensning under anvendelse af ultrafiltrering
|
US7673757B2
(en)
*
|
2006-02-17 |
2010-03-09 |
Millipore Corporation |
Adsorbent filter media for removal of biological contaminants in process liquids
|
MX2008013494A
(es)
*
|
2006-04-20 |
2009-01-26 |
Wyeth Corp |
Procesos de purificacion para aislar virus puirificado de la estomatitis vesicular provenientes de cultivo celular.
|
EP2173861B2
(en)
*
|
2007-06-15 |
2017-02-22 |
Amgen Inc. |
Methods of treating cell culture media for use in a bioreactor
|
PL2307551T3
(pl)
|
2008-06-18 |
2017-07-31 |
Oxford Biomedica (Uk) Limited |
Oczyszczanie wektorów retrowirusowych
|
JP5770633B2
(ja)
*
|
2008-11-03 |
2015-08-26 |
クルセル ホランド ベー ヴェー |
アデノウイルスベクターの産生方法
|
JP2010207800A
(ja)
*
|
2009-02-16 |
2010-09-24 |
Kuraray Co Ltd |
ろ過ユニットおよびこれを備えたろ過装置
|
BR112012008516B1
(pt)
*
|
2009-10-15 |
2021-10-19 |
Janssen Vaccines & Prevention B.V. |
Método para purificar partículas de adenovírus a partir de uma suspensão de célula
|
AU2010305768B2
(en)
*
|
2009-10-15 |
2015-05-14 |
Crucell Holland B.V. |
Process for adenovirus purification from high cell density cultures
|
AU2011214262B2
(en)
|
2010-02-15 |
2015-05-21 |
Crucell Holland B.V. |
Method for the production of Ad26 adenoviral vectors
|
US9644187B2
(en)
|
2010-04-14 |
2017-05-09 |
Emd Millipore Corporation |
Methods of producing high titer, high purity virus stocks and methods of use thereof
|
NZ603620A
(en)
|
2010-07-20 |
2015-01-30 |
Bavarian Nordic As |
Method for harvesting expression products
|
TWI503411B
(zh)
*
|
2010-08-11 |
2015-10-11 |
Nat Health Research Institutes |
B群腦膜炎球菌次單位疫苗之製造及純化
|
DE102010046817A1
(de)
*
|
2010-09-28 |
2012-03-29 |
Sartorius Stedim Biotech Gmbh |
Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
SI2825640T1
(sl)
|
2012-03-12 |
2016-08-31 |
Crucell Holland B.V. |
Šarže rekombinantnega adenovirusa s spremenjenimi konci
|
CN104334188B
(zh)
|
2012-03-22 |
2016-08-24 |
克鲁塞尔荷兰公司 |
抗rsv疫苗
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
CN104884933B
(zh)
*
|
2012-10-18 |
2019-03-01 |
伊诺瓦普瑞普有限公司 |
液体向液体的生物粒子分级和浓缩
|
PL2988780T3
(pl)
|
2013-04-25 |
2019-06-28 |
Janssen Vaccines & Prevention B.V. |
Stabilizowane rozpuszczalne prefuzyjne polipeptydy F RSV
|
AP2015008893A0
(en)
|
2013-06-17 |
2015-12-31 |
Crucell Holland Bv |
Stabilized soluble pre-fusion rsv f polypeptides
|
CN116656627A
(zh)
*
|
2013-07-11 |
2023-08-29 |
宝生物工程株式会社 |
制备无包膜病毒的方法
|
CN105612250A
(zh)
*
|
2013-10-07 |
2016-05-25 |
诺华股份有限公司 |
经处理的滤器
|
EP3105348B1
(en)
*
|
2014-02-10 |
2019-08-21 |
Zymo Research Corporation |
Methods of nucleic acid capture
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
WO2016006658A1
(ja)
|
2014-07-10 |
2016-01-14 |
タカラバイオ株式会社 |
非エンベロープウイルス粒子の製造方法
|
BR112017001177B1
(pt)
|
2014-07-24 |
2022-05-24 |
Janssen Vaccines & Prevention B.V |
Método de purificação e de potenciação da liberação de poliovírus a partir de uma colheita de cultura celular bruta contendo poliovírus e uso de um detergente catiônico
|
WO2016073693A2
(en)
|
2014-11-05 |
2016-05-12 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
US10597660B2
(en)
|
2014-11-14 |
2020-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
SG11201703419UA
(en)
|
2014-11-14 |
2017-05-30 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
EP3243904A4
(en)
*
|
2015-01-09 |
2018-06-27 |
Takara Bio Inc. |
Method for producing non-enveloped viral particles
|
EP3245218A4
(en)
|
2015-01-13 |
2018-10-03 |
Alfa Wassermann, Inc. |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) and gradients and flow-through buffers therefore
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
AU2016249798B2
(en)
|
2015-04-14 |
2022-05-26 |
Janssen Vaccines And Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
EA039065B1
(ru)
|
2015-07-07 |
2021-11-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
JP6840718B2
(ja)
|
2015-07-07 |
2021-03-10 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. |
安定化された可溶性融合前rsv fポリペプチド
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
ES2858315T3
(es)
|
2016-04-05 |
2021-09-30 |
Janssen Vaccines & Prevention Bv |
Proteína F de prefusión de VRS soluble estabilizada para uso en la profilaxis de la infección por VRS
|
PE20190433A1
(es)
|
2016-04-05 |
2019-03-21 |
Janssen Vaccines And Prevention B V |
Vacuna contra vrs
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
BR112018072865A2
(pt)
|
2016-05-12 |
2019-04-30 |
Janssen Vaccines & Prevention B.V. |
promotor bidirecional potente e equilibrado
|
EP3458589A4
(en)
|
2016-05-18 |
2020-01-01 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
|
KR20240056729A
(ko)
|
2016-05-18 |
2024-04-30 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
IL264119B2
(en)
|
2016-05-30 |
2023-04-01 |
Janssen Vaccines Prevention B V |
f proteins of rsv are stabilized before fusion
|
MX2018015540A
(es)
|
2016-06-20 |
2019-04-11 |
Janssen Vaccines & Prevention Bv |
Promotor bidireccional potente y equilibrado.
|
JP7229151B2
(ja)
|
2016-07-14 |
2023-02-27 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
Hpvワクチン
|
CN110650673B
(zh)
|
2016-08-30 |
2024-04-09 |
加利福尼亚大学董事会 |
用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
|
CA3040288A1
(en)
*
|
2016-11-04 |
2018-07-12 |
Baxalta Incorporated |
Adeno-associated virus purification methods
|
US10294452B2
(en)
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
CN108085301B
(zh)
*
|
2016-11-22 |
2021-10-26 |
贺道耀 |
从宿主细胞提取和纯化腺相关病毒和腺病毒的方法及其组分和试剂盒
|
CN110268061A
(zh)
|
2017-02-09 |
2019-09-20 |
扬森疫苗与预防公司 |
用于表达异源基因的有效的短启动子
|
US11603542B2
(en)
|
2017-05-05 |
2023-03-14 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
ハンチントン病治療組成物および方法
|
JP2020519663A
(ja)
|
2017-05-17 |
2020-07-02 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. |
Rsv感染に対する防御免疫を誘導するための方法及び組成物
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
EP3654860A1
(en)
|
2017-07-17 |
2020-05-27 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
AU2018333566A1
(en)
|
2017-09-15 |
2020-02-27 |
Janssen Vaccines & Prevention B.V. |
Method for the safe induction of immunity against RSV
|
AU2018352236A1
(en)
|
2017-10-16 |
2020-04-23 |
The Curators Of The University Of Missouri |
Treatment of amyotrophic lateral sclerosis (ALS)
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
EP3762500A1
(en)
|
2018-03-06 |
2021-01-13 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
JP7048889B2
(ja)
*
|
2018-04-16 |
2022-04-06 |
日本電信電話株式会社 |
バクテリア産生セルロースカーボンの製造方法
|
US20210047626A1
(en)
|
2018-04-24 |
2021-02-18 |
Merck Sharp & Dohme Corp. |
Scalable chromatography process for purification of human cytomegalovirus
|
WO2019212921A1
(en)
*
|
2018-04-29 |
2019-11-07 |
Regenxbio Inc. |
Scalable clarification process for recombinant aav production
|
KR20210021473A
(ko)
|
2018-05-15 |
2021-02-26 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
푸소솜 조성물 및 그의 용도
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
WO2019222441A1
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
EP3818161A1
(en)
|
2018-07-02 |
2021-05-12 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
JP2022507453A
(ja)
|
2018-11-14 |
2022-01-18 |
フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド |
T細胞送達のためのフソソーム組成物
|
WO2020102485A1
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
CA3120082A1
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
TW202039858A
(zh)
|
2019-01-18 |
2020-11-01 |
美商航海家醫療公司 |
用於生產aav顆粒之方法及系統
|
WO2020223274A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
GB201909081D0
(en)
*
|
2019-06-25 |
2019-08-07 |
Psioxus Therapeutics Ltd |
Method
|
WO2021030125A1
(en)
|
2019-08-09 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
US20220364114A1
(en)
|
2019-08-26 |
2022-11-17 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
CN111394390A
(zh)
*
|
2020-03-26 |
2020-07-10 |
赛诺(深圳)生物医药研究有限公司 |
用于新型冠状病毒基因疫苗的批量生产重组腺病毒的方法
|
EP3919613A1
(en)
|
2020-06-05 |
2021-12-08 |
Bia Separations D.O.O. |
Enhanced purification of adeno-associated virus to more effectively remove contaminating dna
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
RU2745307C1
(ru)
*
|
2020-12-01 |
2021-03-23 |
федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации |
Способ очистки рекомбинантного аденовируса 26 серотипа (Ad26)
|
US20240033334A1
(en)
*
|
2020-12-04 |
2024-02-01 |
Gritstone Bio, Inc. |
Compositions and methods of use thereof
|
US20240011012A1
(en)
*
|
2020-12-21 |
2024-01-11 |
Pfizer Inc. |
Methods and compositions for inhibiting excess nucleic acid precipitation
|
US20240141377A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
GB202117844D0
(en)
|
2021-12-09 |
2022-01-26 |
Oxford Biomedica Ltd |
Purification method
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
CN115747017B
(zh)
*
|
2022-10-25 |
2023-06-09 |
上海华新生物高技术有限公司 |
一种腺病毒纯化装置
|